Today, the Minneapolis Heart Institute Foundation and Mayo Clinic posted video presentations from the Riata ICD Lead Summit on the meeting website at www.mplsheart.org/riata. Videos from all of the Summit's presentations and two panel sessions will be available by the end of the week.
The conference, held Jan. 20, 2012, in Minneapolis, brought together clinical leaders from over 22 states to discuss the recent Class I FDA recall on Riata and Riata ST implantable cardioverter-defibrillator (ICD) leads. Approximately 80,000 patients have Riata or Riata ST ICD leads in the U.S. Presentations addressed current data on lead failure, fluoroscopic examination of Riata leads, extraction methods and follow-up options for patients with Riata leads.
"We need more information to safely and effectively manage our Riata patients," said Robert G. Hauser, MD, senior consulting cardiologist, Minneapolis Heart Institute® at Abbott Northwestern Hospital. Hauser and David L. Hayes, MD, professor of medicine at Mayo Clinic, served as course directors for the summit.
Attendance was restricted to clinical professionals who care for ICD patients. Representatives from St. Jude Medical and cardiovascular education professionals were also invited to attend.
"Now we want to share what we learned at the Summit and move toward developing a consensus regarding the best treatment strategy for these patients," Hauser commented.
The summit featured the initial results from an independent multicenter study of Riata ICD leads, the VA National Cardiac Device Surveillance Center study and the Northern Ireland Experience.
Minneapolis Heart Institute Foundation
The Minneapolis Heart Institute Foundation (MHIF) is dedicated to creating a world without heart disease through groundbreaking clinical research and innovative education programs. MHIF's mission is to promote and improve cardiovascular health, quality of life and longevity for all.